Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 4, 1996, Pages 1548-1551

  Russo, Diego ^a   Arturi, Franco ^a   Suarez, Horacio G ^b   Schlumberger, Martin ^c   Du Villard, Jean Antoine ^b   Crocetti, Umberto ^a   Filetti, Sebastiano ^a,d  

^a UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

^b CNRS   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d Policlinico Mater Domini   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN; THYROTROPIN RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CODON; GENE MUTATION; GENETIC CODE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT TRANSFORMATION; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; THYROID ADENOMA; THYROTROPIN BLOOD LEVEL; THYROTROPIN RELEASE;

ADENOMA; AMINO ACID SEQUENCE; BASE SEQUENCE; CODON; DNA PRIMERS; EXONS; GENE FREQUENCY; HUMANS; MOLECULAR SEQUENCE DATA; POINT MUTATION; POLYMERASE CHAIN REACTION; RECEPTORS, THYROTROPIN; THYROID GLAND; THYROID NEOPLASMS;

EID: 0029964174     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.4.1548     Document Type: Article

References (28)

1. Lyons J, Landis CA, Harsh G, et al. 1990 Two G protein oncogene, in human endocrine tumors. Science. 249:655-659.
2. Vassart G, Parma J, Van Sande J, Dumont JE. 1994 The thyrotropin receptor and the regulation of thyrocyte function and growth: update 1994. Endocr Rev. 3:1;77-80.
3. Russo D, Arturi F, Schlumberger M, et al. 1995 Activating mutations of the TSH receptor in differentiated thyroid carcinomas. Oncogene 11:1907-1911.
4. Said S, Schlumberger M, Suarez HG. 1994 Oncogenes and anti-oncogenes in human epithelial thyroid tumors. J Endocrinol Invest. 17:371-379.
5. O' Sullivan C, Barton CM, Staddon SL, Brown CL, Lemoine NR. 1991 Activating point mutations of the gsp oncogene in human thyroid adenomas. Mol Carcinog. 4:345-349.
6. Hamacher C, Studer H, Zbaeren J, Schatz H, Derwahl M. 1995 Expression of functional stimulatory guanine nucleotide binding protein in nonfunctioning thyroid adenomas is not correlated to adenyl cyclase activity and growth of these tumors. J Clin Endocrinol Metab. 80:1724-1732.
7. Parma J, Duprez L, Van Sande J, et al. 1993 Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature. 365:649-651.
8. Porcellini A, Ciullo I, Laviola L, Amabile G, Fenzi G, Avvedimento VE. 1994 Novel mutations of thyrotropin receptor in thyroid hyperfunctioning adenomas. Rapid identification by fine needle aspiration biopsy. J Clin Endocrinol Metab. 79:657-661.
9. Paschke R, Tonacchera M, Van Sande J, Parma J, Vassart G. 1994 Identification and functional characterization of two new somatic mutations causing constitutive activation of the thyrotropin receptor in hyperfunctioning autonomous adenomas of the thyroid. J Clin Endocrinol Metab. 79:1785-1789.
10. Takeshita A, Nagayama Y, Yokoyama N, et al. 1995 Rarity of oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in Japan. J Clin Endocrinol Metab. 80:2607-2611.
11. Russo D, Arturi F, Wicker R, et al. 1995 Genetic alterations in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab. 80:1347-1351.
12. 2+ cascades. Mol Endocrinol. 9:725-733.
13. Lefkowitz RJ, Cotecchia S, Samama P, Costa T. 1993 Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol Sci. 14:303-307.
14. Chazenbalk GD, Nagayama Y, Russo D, Wadsworth HL, Rapoport B. 1990 Functional analysis of the cytoplasmic domains of the human thyrotropin receptor by site-directed mutagenesis. J Biol Chem. 265:20970-20975.
15. Gross B, Misrahi M, Sar S, Milgrom E. 1991 Composite structure of the human thyrotropin receptor gene. Biochem Biophys Res Commun. 177:679-687.
16. Hedinger C, Williams ED, Sabin LH. 1989 The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer. 63:908-911.
17. Suarez HG, Du Villard JA, Severino M, et al. 1990 Presence of mutations in all three ras genes in human thyroid tumors. Oncogene. 5:565-570.
18. Nagayama Y, Kaufman KD, Seto P, Rapoport B. 1989 Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor. Biochem Biophys Res Commun. 165:1184-1190.
19. Libert F, Lefort A, Gerard C, et al. 1989 Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies. Biochem Biophys Res Commun. 165:1250-1255.
20. Misrahi M, Loosfelt H, Atger M, Sar S, Guiochon-Mantel A, Milgrom E. 1990 Cloning, sequencing and expression of human TSH receptor. Biochem Biophys Res Commun. 166:394-403.
21. Sanger F, Nicklen S, Coulson AR. 1977 DNA sequencing with chain terminating inhibition. Proc Natl Acad Sci USA. 82:488-492.
22. Kosugi S, Shenker A, Mori T. 1994 Constitutive activation of cyclic AMP but not phosphatidylinositol signaling caused by four mutations in the 6th transmembrane helix of the human thyrotropin receptor. FEBS Lett. 356:291-294.
23. Lefkowitz RJ. 1995 G Proteins in medicine. N Engl J Med 332:186-187.
24. Shenker A. 1995 G Protein-coupled receptor mutations. Bailliere Clin Endocrinol Metab. 9:427-451.
25. Fagin JA. 1992 Molecular defects in thyroid gland neoplasia. J Clin Endocrinol Metab. 75:1398-1400.
26. Fand NR, Shi Y, Zou M. 1994 Molecular basis of thyroid cancer. Endocr Rev. 15:202-232.
27. Bertherat J, Chanson P, Montminy M. 1995 The cyclic adenosine 3′,5′-monophosphate-responsive factor CREB is constitutively activated in human somatotroph adenomas. Mol Endocrinol. 9:777-783.
28. Van Sande J, Parma J, Tonacchera M, Swillens S, Dumont J, Vassart G. 1995 Somatic and germline mutations of the TSH receptor gene in thyroid diseases. J Clin Endocrinol Metab. 80:2577-2585.